← 返回

人 NK 细胞来源外泌体递送用于肝癌治疗:皮下与原位动物模型体内研究

英文原题:Delivery of human natural killer cell-derived exosomes for liver cancer therapy: an in vivo study in subcutaneous and orthotopic animal models.

查看英文原题

Delivery of human natural killer cell-derived exosomes for liver cancer therapy: an in vivo study in subcutaneous and orthotopic animal models.

PubMed 2022/12/01(内容时间) Drug Deliv Q1 · IF 8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

外泌体是由多种细胞类型分泌的纳米级细胞外囊泡,包括免疫系统中的自然杀伤(NK)细胞。它们通过在不同细胞间转运信号分子,在细胞间通讯中发挥作用。近期研究报道,NK细胞来源的外泌体(NK-exo)含有可诱导细胞死亡的细胞毒性蛋白。

然而,NK-exo的特征及其潜在功能,尤其是在肝癌中的功能,仍知之甚少。在本研究中,我们利用原位和皮下肿瘤模型,研究了NK-exo在原发性肝癌——肝细胞癌(HCC)中的抗肿瘤作用。

我们发现,NK-exo同时表达典型的外泌体标志物(如CD63、CD81和Alix)和细胞毒性蛋白(如perforin、granzyme B、FasL和TRAIL)。NK-exo可被HCC细胞(如Hep3B、HepG2和Huh 7)选择性摄取。有趣的是,与HepG2和Huh7细胞相比,Hep3B细胞诱导的细胞毒性最高,并且NK-exo显著增强了其凋亡。

此外,我们证明NK-exo抑制了丝氨酸/苏氨酸蛋白激酶(如AKT和ERK1/2)的磷酸化,并增强了Hep3B细胞中特定凋亡标志物(如caspase-3、-7、-8、-9和PARP)的活化。NK-exo在原位和皮下HCC小鼠模型中还表现出主动靶向能力和强效治疗作用。

总体而言,这些结果表明NK-exo在HCC中具有强大的抗肿瘤作用,其由涉及丝氨酸/苏氨酸激酶通路相关细胞增殖和caspase活化通路相关凋亡的新型调控机制所介导。

展开英文摘要原文

Exosomes are nanosized extracellular vesicles secreted by various cell types, including those of the immune system, such as natural killer (NK) cells. They play a role in intercellular communication by transporting signal molecules between the cells. Recent studies have reported that NK cell-derived exosomes (NK-exo) contain cytotoxic proteins-induced cell death.

However, the characteristics and potential functions of NK-exo, especially for the liver cancer are poorly understood. In this study, we investigated the anti-tumor effects of NK-exo in the primary liver cancer, hepatocellular carcinoma (HCC), using the orthotopic and subcutaneous tumor model.

We found that NK-exo expressed both typical exosomal markers (e. g. CD63, CD81, and Alix) and cytotoxic proteins (e. g. perforin, granzyme B, FasL, and TRAIL). NK-exo were selectively taken up by HCC cells (e. g. Hep3B, HepG2, and Huh 7). Interestingly, Hep3B cells induced the highest cytotoxicity compared with HepG2 and Huh7 cells, and substantially enhanced the apoptosis by NK-exo.

Furthermore, we demonstrated that NK-exo inhibited the phosphorylation of serine/threonine protein kinases (e. g. AKT and ERK1/2), and enhanced the activation of specific apoptosis markers (e. g. caspase-3, -7, -8, -9, and PARP) in Hep3B cells. NK-exo also exhibit the active targeting ability and potent therapeutic effects in both orthotopic and subcutaneous HCC mouse models.

Overall, these results suggest that NK-exo indicate strong anti-tumor effects in HCC, which are mediated by novel regulatory mechanisms involved in serine/threonine kinase pathway-associated cell proliferation and caspase activation pathway-associated apoptosis.

论文信息

作者
Kim HY、Min HK、Song HW、Yoo A、Lee S、Kim KP、Park JO、Choi YH
单位
Korea Institute of Medical Microrobotics, Buk-gu, Gwangju, Republic of Korea.South Korea
期刊
Drug delivery2022 Dec
原文标识
PubMed 36068970 · DOI 10.1080/10717544.2022.2118898